Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Pancreatic Cancer

Clinical trial condition

Recurrent Pancreatic Cancer

Explore clinical trials studying Recurrent Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

43 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Pancreatic Cancer trial results

Completed

UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00039403

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00075647

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details